Clinical trials
Phase 1/2 trials in Belgium with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universitair Ziekenhuis Brussel | 5 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 3 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Celyad Oncology SA | 1 |
| Commissie Voor Klinisch Toegepast Onderzoek | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fast Forward Pharmaceuticals | 1 |
| Glycostem Therapeutics BV | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
| Jean Schoenen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Melanoma | 3 |
| Diabetes Mellitus, Type 1 | 2 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Squamous Cell | 1 |
| Congenital Abnormalities | 1 |
| Coronavirus Infections | 1 |
| Crohn Disease | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.